Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients With Reduced and Mildly Reduced Ejection Fraction - 23/05/25

Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
An echocardiographic algorithm to estimate pulmonary capillary wedge pressure (ePCWP) and pulmonary vascular resistance (ePVR) has been recently validated versus right heart catheterization.
Objective |
To assess the prognostic significance of these measures in heart failure (HF) patients with reduced and mildly reduced ejection fraction.
Methods |
Consecutive outpatients with HF and left ventricular ejection fraction (LVEF) <50% undergoing echocardiography were selected and followed up for the composite end point of all-cause death or HF hospitalization.
Results |
Out of 2,214 patients (71 ± 12 years, 76% males, LVEF 35% ± 9%), ePCWP (16 ± 6 mm Hg) was elevated (>15 mm Hg) in 52% of cases and ePVR (1.7 ± 0.7 Wood units) was elevated (>2 Wood units) in 25% of cases. Patients with increased ePCWP were older and had a higher New York Heart Association class, more pronounced cardiac remodeling, systolic/diastolic dysfunction, and neurohormonal activation, particularly when ePVR was also elevated (P < .001). Over a median follow-up of 33 (17-48) months, both measures stratified patients for the risk of the primary end point (log-rank 151 for ePCWP and 60 for ePVR; P < .001). At adjusted regression analysis, ePCWP (hazard ratio for 1 mm Hg increase 1.03 [95% CI, 1.01-1.04]; P < .001) but not ePVR (P = .07) predicted the primary end point, even in patients with atrial fibrillation (P = .019), outperforming current diastolic dysfunction grading (P < .001) and both E/e’ and left atrial volume index (P < .001). The addition of ePCWP to a multivariable prognostic model improved the accuracy of risk prediction (P < .001).
Conclusion |
The echocardiographic estimates of PCWP retained clinical and prognostic significance in a large contemporary cohort of patients with chronic HF and LVEF <50%.
Le texte complet de cet article est disponible en PDF.Central Illustration |
A quantitative echocardiographic algorithm to estimate PCWP retains clinical and prognostic significance in HF patients with LVEF <50%, even in patients with AF, outperforming both E/e’ and LAVi and current diastolic dysfunction grading and improving the accuracy of risk prediction of a multivariable prognostic model.
A quantitative echocardiographic algorithm to estimate PCWP retains clinical and prognostic significance in HF patients with LVEF <50%, even in patients with AF, outperforming both E/e’ and LAVi and current diastolic dysfunction grading and improving the accuracy of risk prediction of a multivariable prognostic model.
Central IllustrationA quantitative echocardiographic algorithm to estimate PCWP retains clinical and prognostic significance in HF patients with LVEF <50%, even in patients with AF, outperforming both E/e’ and LAVi and current diastolic dysfunction grading and improving the accuracy of risk prediction of a multivariable prognostic model.Le texte complet de cet article est disponible en PDF.
Highlights |
• | Elevated LV filling pressures correlate to clinical severity and outcomes in HF. |
• | An echocardiographic algorithm to estimate PCWP and PVR has been recently validated. |
• | ePCWP predicted all-cause death and HF hospitalization in HFrEF and HFmrEF patients. |
• | ePCWP retained its prognostic efficacy even in patients with AF. |
• | ePCWP outperformed current diastolic dysfunction grading in risk prediction. |
Keywords : Pulmonary capillary wedge pressure, Filling pressures, Echocardiography, Diastolic function, Chronic heart failure
Abbreviations : AF, CO, COPD, eGFR, ePCWP, ePVR, HF, HFmrEF, HFpEF, HFrEF, HR, ICD, IVCd, LAVi, LV, LVAD, LVEF, mPAP, NT-proBNP, NYHA, PCWP, PVR, RAP, RHC, RVFAC, SCD, sPAP, SV, TAPSE, WU
Plan
| Drs. Bazan and Gentile contributed equally to this work. |
|
| Drs. Chubuchny and Giannoni contributed equally to this work. |
|
| Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
